Abstract
Background Menstrual symptoms may negatively impact pupils’ attendance and educational attainment, but rigorous population-based studies are lacking.
Methods In a prospective cohort study in England, we assessed associations of self-reported heavy or prolonged bleeding and menstrual pain with school absences and attainment, adjusting for potential confounders.
Findings Of 2,698 participants, 36% reported heavy or prolonged bleeding and 56% reported menstrual pain. Heavy or prolonged bleeding was associated with missing 1·7 additional days of school per year (16·58%; 95% CI: 9·43, 24·20), and 48% higher odds of being persistently absent (≥10% absent) (OR 1·48; 95% CI: 1·45, 1·52). Menstrual pain was associated with missing 1·2 additional days of school per year (12·83%; 95% CI: 6·14, 19·95), and 42% higher odds of being persistently absent (OR 1·42; 95% CI: 1·39, 1·46). Heavy or prolonged bleeding was associated with lower scores in compulsory examinations taken at age 16 (−5·7 points; 95% CI: −10·1, −1·2, equating to one lower grade), and with 27% lower odds of achieving five standard passes (OR 0·73; 95% CI: 0·71, 0·75). There was less evidence of an association between menstrual pain and examination scores (−3·14 points; 95% CI: - 7·46, 1·17), but menstrual pain was associated with 16% lower odds of achieving five standard passes (OR 0·84; 95 CI: 0·81, 0·86).
Interpretation Both heavy or prolonged bleeding and menstrual pain were associated with lower school attendance and educational attainment. Greater research and support are needed to enable girls to achieve their full academic potential.
Funding Wellcome Trust and UK Medical Research Council.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The UK Medical Research Council and Wellcome (Grant ref: 217065/Z/19/Z) and the University of Bristol provide core support for ALSPAC. This publication is the work of the authors and they will serve as guarantors for the contents of this paper. This research was funded in whole, or in part, by the Wellcome Trust and Gemma Sawyer is supported by a Wellcome Trust PhD studentship in Molecular, Genetic, and Lifecourse Epidemiology (218495, https://doi.org/10.35802/218495). For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission. A comprehensive list of grants funding is available on the ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee (IRB00003312) and Local Research Ethics Committees.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵† Joint senior authors
Data Availability
ALSPAC data access is through a system of managed open access. To find out more and apply for access to the data included in this paper and all other ALSPAC data, please visit the ALSPAC website or email alspac-data{at}bristol.ac.uk.
